Report Details:
15 Companies Covered
85 Pages
Home Healthcare Market Highlights
The Global Home Healthcare Market size was valued at USD 355.00 Billion in 2025, and the market is projected to grow from USD 382.20 Billion in 2026 to USD 742.70 Billion by 2035, registering a CAGR of 7.65% during the forecast period 2026–2035.
The global home healthcare market refers to the provision of medical and non-medical services to individuals in their own homes. It includes a wide range of services such as skilled nursing care, personal care assistance, physical therapy, medical equipment rental, and monitoring services.
Segment Analysis
The global Home Healthcare Market has been segmented based Product, Service, and Indication.
The market segmentation, based on Product, includes Testing, Screening and Monitoring Products, Blood Glucose Monitors, Blood Pressure Monitors, Pulse Oximeters, Peak Flow Meters, Heart Rate Monitors, Fetal Monitoring Devices, HIV Test Kits, Home Sleep Testing Devices, Others.
The Blood Pressure Monitors segment held the majority share in the Home Healthcare revenue. This can be attributed to the growing awareness among consumers about the importance of monitoring their blood pressure at home. Additionally, the availability of advanced and technologically advanced blood pressure monitors at affordable prices has also contributed to the segment's growth.
Based on Service, the market segmentation includes Skilled Nursing Services, Rehabilitation Therapy Services, Hospice, and Palliative Care Services, Unskilled Care Services, Respiratory Therapy Services, Infusion Therapy Services, and Others. The Skilled Nursing Services segment is projected to be the faster-growing segment during the forecast period, 2025-2035.
The growth of this segment is driven by the increasing demand for skilled nursing services due to the aging population and the rising prevalence of chronic diseases.
Based on the Indication, the market segmentation includes Cardiovascular Disorders and Hypertension, Diabetes, Respiratory Diseases, Pregnancy, Mobility Disorders, Hearing Disorders, Cancer, Wound Care, Other. The Cardiovascular Disorders and Hypertension segment dominated the market in 2024. The segment's growth is driven by the increasing prevalence of cardiovascular diseases and the growing awareness of the benefits of home healthcare.
Key Players:
MRFR recognizes the following companies as the key players in the Home Healthcare Market — Koninklijke Philips, F. Hoffmann-La Roche, A&D Company, Fresenius SE & Co, Abbott, GE Healthcare, Axxess, CVS Pharmacy, Becton Dickinson Company, Omron Corporation, Medtronic, LG Electronics, Kinnser Software, Apple, and 3M
Regional Analysis
The global Home Healthcare Market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. The North American region is predicted to hold the first position in the market for home healthcare owing to the rising demand for home healthcare and an increase in the number of clinics and hospitals that are providing treatment for home healthcare.
In America, the North American market is the largest market owing to the presence of the key market players in the market that provide both products and instruments for home healthcare.
Europe region accounts for the second-largest Home Healthcare market share. This is because European counties normally have a high population with an increasingly aging population. This is influencing the demand for Home Healthcare products and services in the industry.
Asia-Pacific is estimated to rise at the fastest CAGR of the market due to the increasing number of incidences of chronic diseases, increasing demand for effective healthcare remedies, technological advancement in the healthcare industry, and geographical expansion of the Home Healthcare market.
Key Findings of the Study
- Cardiovascular conditions accounted for 24.70% of the 2025 Home Healthcare Market revenue mix, reflecting high demand for portable cardiac monitors.
- Diabetes care is projected to grow at an 11.70% CAGR through 2035, propelled by the global surge in continuous glucose monitoring adoption.
- North America dominated the Home Healthcare Market with a 39.20% share in 2025.
- Asia-Pacific is poised for the fastest regional CAGR of 10.15% over the forecast window.
